These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 25501510)
1. Epstein-Barr virus latent antigens EBNA3C and EBNA1 modulate epithelial to mesenchymal transition of cancer cells associated with tumor metastasis. Gaur N; Gandhi J; Robertson ES; Verma SC; Kaul R Tumour Biol; 2015 Apr; 36(4):3051-60. PubMed ID: 25501510 [TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus nuclear antigen 1 (EBNA1) protein induction of epithelial-mesenchymal transition in nasopharyngeal carcinoma cells. Wang L; Tian WD; Xu X; Nie B; Lu J; Liu X; Zhang B; Dong Q; Sunwoo JB; Li G; Li XP Cancer; 2014 Feb; 120(3):363-72. PubMed ID: 24190575 [TBL] [Abstract][Full Text] [Related]
3. Zinc finger E-box binding factor 1 plays a central role in regulating Epstein-Barr virus (EBV) latent-lytic switch and acts as a therapeutic target in EBV-associated gastric cancer. Zhao J; Jin H; Cheung KF; Tong JH; Zhang S; Go MY; Tian L; Kang W; Leung PP; Zeng Z; Li X; To KF; Sung JJ; Yu J Cancer; 2012 Feb; 118(4):924-36. PubMed ID: 21717425 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of ZNF746 suppresses invasion and epithelial to mesenchymal transition in H460 non-small cell lung cancer cells. Kim B; Sohn EJ; Jung JH; Shin EA; You OH; Im J; Kim SH Oncol Rep; 2014 Jan; 31(1):73-8. PubMed ID: 24145959 [TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus latent nuclear antigens can induce metastasis in a nude mouse model. Kaul R; Murakami M; Choudhuri T; Robertson ES J Virol; 2007 Oct; 81(19):10352-61. PubMed ID: 17634231 [TBL] [Abstract][Full Text] [Related]
6. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases. Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells. Hong KO; Kim JH; Hong JS; Yoon HJ; Lee JI; Hong SP; Hong SD J Exp Clin Cancer Res; 2009 Feb; 28(1):28. PubMed ID: 19243631 [TBL] [Abstract][Full Text] [Related]
8. ABCG2/BCRP gene expression is related to epithelial-mesenchymal transition inducer genes in a papillary thyroid carcinoma cell line (TPC-1). Mato E; González C; Moral A; Pérez JI; Bell O; Lerma E; de Leiva A J Mol Endocrinol; 2014 Jun; 52(3):289-300. PubMed ID: 24643400 [TBL] [Abstract][Full Text] [Related]
9. Dissecting the contribution of EBNA3C domains important for EBV-induced B-cell growth and proliferation. Jha HC; Shukla SK; Lu J; Aj MP; Banerjee S; Robertson ES Oncotarget; 2015 Oct; 6(30):30115-29. PubMed ID: 26336822 [TBL] [Abstract][Full Text] [Related]
10. Mesenchymal phenotype after chemotherapy is associated with chemoresistance and poor clinical outcome in esophageal cancer. Hara J; Miyata H; Yamasaki M; Sugimura K; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y Oncol Rep; 2014 Feb; 31(2):589-96. PubMed ID: 24297447 [TBL] [Abstract][Full Text] [Related]
11. IBP regulates epithelial-to-mesenchymal transition and the motility of breast cancer cells via Rac1, RhoA and Cdc42 signaling pathways. Zhang Z; Yang M; Chen R; Su W; Li P; Chen S; Chen Z; Chen A; Li S; Hu C Oncogene; 2014 Jun; 33(26):3374-82. PubMed ID: 23975422 [TBL] [Abstract][Full Text] [Related]
12. Galectin-9 Facilitates Epstein-Barr Virus Latent Infection and Lymphomagenesis in Human B Cells. Xu JX; Zhang R; Huang DJ; Tang Y; Ping LQ; Huang BJ; Huang HQ; Busson P; Li J Microbiol Spectr; 2023 Feb; 11(1):e0493222. PubMed ID: 36622166 [TBL] [Abstract][Full Text] [Related]
13. ERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFR. Thomas C; Rajapaksa G; Nikolos F; Hao R; Katchy A; McCollum CW; Bondesson M; Quinlan P; Thompson A; Krishnamurthy S; Esteva FJ; Gustafsson JÅ Breast Cancer Res; 2012 Nov; 14(6):R148. PubMed ID: 23158001 [TBL] [Abstract][Full Text] [Related]
14. PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma. Chen W; Wu J; Shi W; Zhang G; Chen X; Ji A; Wang Z; Wu J; Jiang C Cancer Sci; 2021 Jun; 112(6):2158-2172. PubMed ID: 33587761 [TBL] [Abstract][Full Text] [Related]
15. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. Korpal M; Lee ES; Hu G; Kang Y J Biol Chem; 2008 May; 283(22):14910-4. PubMed ID: 18411277 [TBL] [Abstract][Full Text] [Related]
16. The Epstein-Barr virus causes epithelial-mesenchymal transition in human corneal epithelial cells via Syk/src and Akt/Erk signaling pathways. Park GB; Kim D; Kim YS; Kim S; Lee HK; Yang JW; Hur DY Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1770-9. PubMed ID: 24569586 [TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus EBNA1 protein regulates viral latency through effects on let-7 microRNA and dicer. Mansouri S; Pan Q; Blencowe BJ; Claycomb JM; Frappier L J Virol; 2014 Oct; 88(19):11166-77. PubMed ID: 25031339 [TBL] [Abstract][Full Text] [Related]
18. Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication. Malecka KA; Dheekollu J; Deakyne JS; Wiedmer A; Ramirez UD; Lieberman PM; Messick TE J Virol; 2019 Oct; 93(20):. PubMed ID: 31142669 [TBL] [Abstract][Full Text] [Related]
19. EBNA1. Frappier L Curr Top Microbiol Immunol; 2015; 391():3-34. PubMed ID: 26428370 [TBL] [Abstract][Full Text] [Related]
20. The ectopic expression of Snail in MDBK cells does not induce epithelial-mesenchymal transition. Izawa G; Kobayashi W; Haraguchi M; Sudo A; Ozawa M Int J Mol Med; 2015 Jul; 36(1):166-72. PubMed ID: 25998899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]